Two Mount Sinai Researchers Elected to National Academy of Medicine
Alison M. Goate, D.Phil, Professor of Neuroscience, Neurology and Genetic and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, and Lynne D. Richardson, MD, FACEP, Professor of Emergency Medicine and Population Health Science and Policy, have been elected as two of 79 new members to the prestigious National Academy of Medicine (NAM), formerly known as The Institute of Medicine (IOM).
“Election to the National Academy of Medicine is considered one of the highest honors in medicine,” says Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai. “The election of Drs. Goate and Richardson is a notable achievement and well-deserved recognition of each of their leadership efforts and important contributions to their particular fields of study.”
Dr. Goate is an internationally renowned neuropsychiatric researcher and the founding Director of The Ronald M. Loeb Center for Alzheimer’s Disease at Mount Sinai. As a molecular geneticist, Dr. Goate has established an international reputation for her research to elucidate the genetic, molecular, and cellular basis of Alzheimer’s disease (AD) and related neurodegenerative disorders. Dr. Goate has identified key gene mutations linked to the heritable risk for Alzheimer’s disease, including her finding that a rare mutation of the PLD3 gene doubles the risk of developing late-onset AD. Prior to joining Mount Sinai, she led a team of researchers at Washington University in St. Louis that performed the largest ever genome-wide association study of protein markers found in cerebrospinal fluid, resulting in the discovery of three genetic variants associated with an increased risk of developing AD.
Dr. Richardson is Professor and Vice Chair of Emergency Medicine and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai. She is a practicing emergency physician and a nationally recognized expert in health services research. Dr. Richardson’s areas of interest are access and barriers to care, improving effective utilization of health care resources, and health care disparities. She is principal investigator (PI) for an NIH-funded study which is seeking to improve effective methods for communicating with communities about emergency research. She is also PI of a trial focused on prevention and early treatment of acute lung injury and of the New York City Sickle Cell Implementation Science Consortium. With a strong track record of mentoring young investigators to successful research careers, Dr. Richardson directs a research career development program in emergency medicine and an emergency care research fellowship program. She also received a Health Care Innovation Award from the Centers for Medicare and Medicaid Services to implement a new model of emergency care for older adults.
New members are elected by current, active members through a selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health. Established in 1970 by the National Academy of Sciences, NAM is a national resource that provides independent, objective analysis and advice on health issues.
The new NAM members bring Mount Sinai’s total membership in the prestigious group to 21. The distinguished Mount Sinai faculty members who Drs. Goate and Richardson join in earning this honor are: • Joseph D. Buxbaum, PhD • Dennis S. Charney, MD • Kenneth L. Davis, MD • Robert J. Desnick, MD, PhD • Kurt W. Deuschle, MD •Angela Diaz, MD, MPH • Valentin Fuster, MD, PhD • Bruce Gelb, MD • E. Cuyler Hammond • Kurt Hirschhorn, MD • Philip J. Landrigan, MD, MSc • Diane E. Meier, MD • Eric J. Nestler, MD, PhD • Maria Iandolo New, MD • Peter Palese, PhD • Hugh A. Sampson, MD • Irving J. Selikoff, MD • Pamela Sklar, MD, PhD • Barbara G. Vickrey, MD, MPH.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology, Mount Sinai St. Lukes and Mount Sinai West are ranked 23rd nationally for Nephrology and 25th for Diabetes/Endocrinology, and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.